Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients.
Eleni M GamvroulasAubrey E JonesJohn A SaundersTara L JonesDaniel M WittPublished in: BMC cardiovascular disorders (2023)
Most anticoagulated patients were continued on antiplatelet therapy 12-months post PCI. Bleeding was numerically more common in anticoagulated patients continuing SAPT therapy beyond 12 months. There was significant variability in antithrombotic prescribing patterns 12-months post PCI suggesting a potential opportunity for standardizing care in this patient population.
Keyphrases
- end stage renal disease
- antiplatelet therapy
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- percutaneous coronary intervention
- acute coronary syndrome
- peritoneal dialysis
- primary care
- emergency department
- coronary artery
- acute myocardial infarction
- mesenchymal stem cells
- heart failure
- palliative care
- pain management
- quality improvement
- climate change
- patient reported outcomes
- st segment elevation myocardial infarction
- chronic pain
- transcatheter aortic valve replacement
- cell therapy
- health insurance